These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4149365)

  • 21. [Effect of a new beta-adrenoceptor blocking agent, carteolol (OPC-1085). Improvement of the coronary collateral circulation in dogs with chronic coronary artery occlusion (author's transl)].
    Ishihara T; Watanabe K; Takenaka F
    Arzneimittelforschung; 1977; 27(11):2055-9. PubMed ID: 23789
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of the effects on renin release of beta adrenergic antagonists with differing properties.
    Weber MA; Stokes GS; Gain JM
    J Clin Invest; 1974 Dec; 54(6):1413-9. PubMed ID: 4154950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Letter: Beta receptors and renin release.
    Amery A; Billiet L; Fagard R
    N Engl J Med; 1974 Jan; 290(5):284. PubMed ID: 4148766
    [No Abstract]   [Full Text] [Related]  

  • 24. The dose-related effects of bolus esmolol on heart rate and blood pressure following laryngoscopy and intubation.
    Bensky KP; Donahue-Spencer L; Hertz GE; Anderson MT; James R
    AANA J; 2000 Oct; 68(5):437-42. PubMed ID: 11759128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The beta-blocking potency and cardioselectivity of tolamolol and its isomers in rodents.
    Adam KR; Baird JR; Burges RA; Linnell J
    Eur J Pharmacol; 1974 Feb; 25(2):170-5. PubMed ID: 4154851
    [No Abstract]   [Full Text] [Related]  

  • 26. Selective beta(1)-adrenoreceptor blocking activity of newly synthesized acyl amino-substituted aryloxypropanolamine derivatives, DPJ 955 and DPJ 890, in rats.
    Nandakumar K; Bansal SK; Singh R; Bodhankar SL; Jindal DP; Coumar MS; Balaraman R; Bhardwaj SH
    J Pharm Pharmacol; 2005 Apr; 57(4):515-9. PubMed ID: 15831214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the beta receptor blocking properties of two analogs of dichloroisoproterenol (DCI).
    Levy B
    J Pharmacol Exp Ther; 1973 Jul; 186(1):123-33. PubMed ID: 4146700
    [No Abstract]   [Full Text] [Related]  

  • 28. [Comparative effects of seven beta adrenolytic agents on blood pressure after injection into the posterior hypothalamus of rats. The frequency heart and the plasma renin activity (author's transl)].
    Bentue-Ferrer D; Allain H; Van den Driessche J; Pape D; Reymann JM
    J Pharmacol; 1981; 12(2):161-77. PubMed ID: 6115097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Beta blocking effects of butofilolol in standard exercise tests in the healthy subjects].
    Letac B; Bousnina A; Cribier A; Berland J
    Ann Cardiol Angeiol (Paris); 1982; 31(5):405-8. PubMed ID: 6130740
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparative study of beta-adrenoceptor blocking efficacy of two formulations of esmolol in vivo and in vitro.
    Tripathi CB; Bhattacharya P; Bhatt JD; Hemavathi KG
    Indian J Physiol Pharmacol; 1999 Apr; 43(2):255-8. PubMed ID: 10365322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Anti-hypertensive action of tenormine in the genetically hypertensive rat].
    Boissier JR; Giudicelli ; Richer C
    Nouv Presse Med; 1975 May; 4(22):1661. PubMed ID: 2904
    [No Abstract]   [Full Text] [Related]  

  • 32. Proceedings: Relationship between the pharmacokinetic and pharmacodynamic properties of the beta-receptor antagonists alprenolol and metoprolol.
    Regardh CG; Ablad B; Borg KO; Johnsson G; Solvell L
    Acta Pharm Suec; 1974 Dec; 11(6):660. PubMed ID: 237405
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of beta receptor blockaders on the atrioventricular stimulus conduction. Study by means of bundle of His electrocardiography].
    Halter J; Pfisterer M; Nager F
    Schweiz Med Wochenschr; 1974 Nov; 104(44):1554-7. PubMed ID: 4153699
    [No Abstract]   [Full Text] [Related]  

  • 34. [Echocardiographic studies of the effect of bunitrolol in healthy subjects ].
    Fernández Iglesias A; García-Barbal J
    Med Clin (Barc); 1982 Jun 16-30; 79(2):59-64. PubMed ID: 6126620
    [No Abstract]   [Full Text] [Related]  

  • 35. Circulatory effects of oxprenolol, a new beta-adrenergic blocking agent.
    Reale A; Motolese M; Imhof P
    Int Z Klin Pharmakol Ther Toxikol; 1970 Jul; 3(3):288-93. PubMed ID: 4394124
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of tolamolol versus propranolol on systolic time intervals in angina.
    Aronow WS; Vawter M; Spivack N; Warren M; Laverty W
    Curr Ther Res Clin Exp; 1974 Oct; 16(10):1069-76. PubMed ID: 4154826
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effects of beta receptor blocking agent, 1-(7-indenyloxy)-3-isopropylaminopropane-2-ol hydrochloride (YB-2) on the circulatory system during intubation for general anesthesia].
    Kim SY; Miyamoto K; Yoshikawa K
    Masui; 1975 Aug; 24(8):780-6. PubMed ID: 240954
    [No Abstract]   [Full Text] [Related]  

  • 38. Cardiovascular effects of YM-16151-4: a novel calcium entry blocking and selective beta 1-adrenoceptor blocking agent in rats and dogs.
    Uchida W; Shibasaki K; Matsuda Y; Asano M; Takenaka T
    J Cardiovasc Pharmacol; 1993 Aug; 22(2):247-52. PubMed ID: 7692165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proceedings: Beta-adrenergic blocking and antiarrhythmic activities of 1-(7-indenyloxy)-3-tert-butylaminopropane-2-OL hydrochloride (YB-11).
    Noguchi Y; Nakao K; Kato H; Takagi K
    Jpn J Pharmacol; 1974; 24(0):s:73. PubMed ID: 4151686
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacokinetics of the new beta-adrenoceptor blocking agent betaxolol (SL 75212) in man after repeated oral administration.
    Bianchetti G; Blatrix C; Gomeni R; Kilborn JR; Larribaud J; Lücker PW; Thebault JJ; Trocherie S; Morselli PL
    Arzneimittelforschung; 1980; 30(11):1912-6. PubMed ID: 6109538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.